Ritonavir News and Research

RSS
Ritonavir, also known as Norvir, is a type of medicine called a protease inhibitor (PI). PIs act by blocking protease, a protein that HIV needs to make more copies of itself. Ritonavir was approved by the FDA on March 1, 1996, for use with other antiretroviral agents in the treatment of HIV infection in adults and children 2 years of age or older. Ritonavir is now approved with other anti-HIV drugs in the treatment of HIV-1 infection in children in individuals over 1 month in age. Studies have shown that ritonavir works as a booster for some other PIs. Taking ritonavir makes it possible to take a lower dose of the other PIs. This medicine does not cure or prevent HIV infection or AIDS and does not reduce the risk of passing the virus to other people.
Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

Control trial proves effectiveness of repurposed drugs for COVID-19 treatment

Lopinavir-ritonavir does not suppress SARS-CoV-2 activity in vitro

Lopinavir-ritonavir does not suppress SARS-CoV-2 activity in vitro

Identifying, preventing and treating drug-induced arrhythmias

Identifying, preventing and treating drug-induced arrhythmias

14 existing drugs identified as SARS-CoV-2 main protease inhibitors

14 existing drugs identified as SARS-CoV-2 main protease inhibitors

Evaluating the use of sofosbuvir and daclatasvir for treatment of COVID-19

Evaluating the use of sofosbuvir and daclatasvir for treatment of COVID-19

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Researchers report a liquid biopsy for COVID-19

Researchers report a liquid biopsy for COVID-19

Hydroxychloroquine is not indicated for COVID-19 under any circumstances

Hydroxychloroquine is not indicated for COVID-19 under any circumstances

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus

Characterizing Polymorphs and Amorphous Form

Characterizing Polymorphs and Amorphous Form

Dutch trial of convalescent plasma in COVID-19 discontinued

Dutch trial of convalescent plasma in COVID-19 discontinued

Life saving drug found for COVID-19 patients on ventilators

Life saving drug found for COVID-19 patients on ventilators

Experimental drug to prevent deadly blood coagulation in patients with COVID-19

Experimental drug to prevent deadly blood coagulation in patients with COVID-19

Hydroxychloroquine ineffective in animal SARS-CoV-2 infection

Hydroxychloroquine ineffective in animal SARS-CoV-2 infection

Antiviral effects for COVID-19: Early is better

Antiviral effects for COVID-19: Early is better

Designing a prototype spike protein vaccine for SARS-CoV-2

Designing a prototype spike protein vaccine for SARS-CoV-2

Does interferon therapy work in COVID-19?

Does interferon therapy work in COVID-19?

Scientists discover two anti-inflammatory drugs that inhibit COVID-19 infection

Scientists discover two anti-inflammatory drugs that inhibit COVID-19 infection

Study evaluates the effectiveness of interferon beta 1b in COVID-19 pneumonia

Study evaluates the effectiveness of interferon beta 1b in COVID-19 pneumonia

The use of rheumatoid arthritis drug sarilumab in severe COVID-19 pneumonia

The use of rheumatoid arthritis drug sarilumab in severe COVID-19 pneumonia